Source: Annual Congress 2011 - Acute breathlessness: the state of the science



Rating:

Share or cite this content

Citations should be made in the following way:
Dyspnoea causal mechanisms and treatment options. Annual Congress 2011 - Acute breathlessness: the state of the science

Member's Comments

No comment yet.

Related content which might interest you: Chronic cough: Are we integrating non-pharmacological therapies into treatment plans? Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017 Underlying mechanisms and pharmacological approaches for treatment of sarcopenia Source: Virtual Congress 2021 – Sarcopenia in chronic respiratory disease: new definitions, assessment and treatment options Year: 2021 Multidimensional approaches to asthma: the need to look beyond drug treatments Source: Annual Congress 2010 - Breathing therapies for asthma Year: 2010 Breathlessness despite optimal pathophysiological treatment: on the relevance of being chronic Source: Eur Respir J, 50 (3) 1701297; 10.1183/13993003.01297-2017 Year: 2017 Breathlessness despite optimal pathophysiological treatment: on the relevance of being chronic Source: Eur Respir J, 50 (3) 1701376; 10.1183/13993003.01376-2017 Year: 2017 Breathlessness despite optimal pathophysiological treatment: on the relevance of being chronic Source: Eur Respir J, 50 (3) 1701159; 10.1183/13993003.01159-2017 Year: 2017 How to manage side-effects of targeted therapies? Source: Annual Congress 2010 - PG7 Postgraduate Course: How to manage treatment complications of lung cancer Year: 2010 Stepping up the controller medication in asthma patients: Impact of various treatment options on costs Source: Annual Congress 2011 - The impact of the organisation of care on costs: the role of the physician in home care Year: 2011 COPD mechanisms: novel aspects and implications for new therapies Source: ERS Live 2007 Year: 2007 COPD: more treatments but no cure? Source: Annual Congress 2011 - The European Respiratory Review 2010 updates: whats hot in pulmonary medicine? Year: 2011 Sleep and breathing in neuromuscular diseases: pathophysiology, screening, and treatment options Source: Sleep and Breathing Conference 2017 Year: 2017 What is the outcome of different management options? Source: Annual Congress 2011 - New ERS Guidelines: Management of Work-Related Asthma Year: 2011 Understanding the pathophysiological mechanisms of cardiometabolic complications in obstructive sleep apnoea: towards personalised treatment approaches Source: Eur Respir J, 56 (2) 1902295; 10.1183/13993003.02295-2019 Year: 2020 Genes, mechanisms and new therapies for asthma Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung Year: 2010 Therapeutic options for IPF Source: Annual Congress 2010 - PG1 Core Curriculum Postgraduate Course: Idiopathic pulmonary fibrosis Year: 2010 Hypoventilation during sleep: risk factors, diagnostic algorithms and therapeutic approaches Source: International Congress 2019 – PG17 Sleep apnoea and hypoventilation: obstruction and more Year: 2019 Current controversies in the treatment of COPD Source: Annual Congress 2011 - Lancet / ERS symposium - New frontiers in COPD Year: 2011